IFNgamma signaling-does it mean JAK–STAT?

Department of Pathology, NYU Cancer Institute, New York University Langone School of Medicine, New York, 10016, USA.
Cytokine & growth factor reviews (Impact Factor: 5.36). 10/2008; 19(5):383-394. DOI: 10.1016/j.cytogfr.2008.08.004


The molecular pathways involved in the cellular response to interferon (IFN)γ have been the focus of much research effort due to their importance in host defense against infection and disease, as well as its potential as a therapeutic agent. The discovery of the JAK–STAT signaling pathway greatly enhanced our understanding of the mechanism of IFNγ-mediated gene transcription. However, in recent years it has become apparent that other pathways, including MAP kinase, PI3-K, CaMKII and NF-κB, either co-operate with or act in parallel to JAK–STAT signaling to regulate the many facets of IFNγ biology in a gene- and cell type-specific manner. The complex interactions between JAK/STAT and alternate pathways and the impact of these signaling networks on the biological responses to IFNγ are beginning to be understood. This review summarizes and appraises current advances in our understanding of these complex interactions, their specificity and proposed biological outcomes.

Download full-text


Available from: David Levy, Dec 18, 2014
  • Source
    • "Differences with reference to IFN-γ may be explained by the expression dynamics of IFN-γ, which is only secreted by a subset of immune cells such as natural killer cells and pathogen-specific T cells. In addition, the IFNGR expression differs and therefore, these effects are not comparable to IFN-α and -λ.104,105,106 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Type-III interferons (IFN-λ, IFNL) are the most recently described family of IFNs. This family of innate cytokines are increasingly being ascribed pivotal roles in host–pathogen interactions. Herein, we will review the accumulating evidence detailing the immune biology of IFNL during viral infection, and the implications of this novel information on means to advance the development of therapies and vaccines against existing and emerging pathogens. IFNLs exert antiviral effects via induction of IFN-stimulated genes. Common single nucleotide polymorphisms (SNPs) in the IFNL3, IFNL4 and the IFNL receptor α-subunit genes have been strongly associated with IFN-α-based treatment of chronic hepatitis C virus infection. The clinical impact of these SNPs may be dependent on the status of viral infection (acute or chronic) and the potential to develop viral resistance. Another important function of IFNLs is macrophage and dendritic cell polarization, which prime helper T-cell activation and proliferation. It has been demonstrated that IFNL increase Th1- and reduce Th2-cytokines. Therefore, can such SNPs affect the IFNL signaling and thereby modulate the Th1/Th2 balance during infection? In turn, this may influence the subsequent priming of cytotoxic T cells versus antibody-secreting B cells, with implications for the breadth and durability of the host response.
    Emerging Microbes and Infections 07/2014; 3(7). DOI:10.1038/emi.2014.51 · 2.26 Impact Factor
  • Source
    • "IL-10 transgenic mice are unable to limit the growth of immunogenic tumors; however, administration of blocking IL-10 mAbs restored in vivo antitumor responses [33]. IFN-γ may exert potent antitumor effects on lung cancer and metastasis, as this cytokine boosts natural killer cell activity, induces macrophage activation and antigen presentation, and activates tumor-specific CD8+CTLs which are required for the elimination of cancer cells [34–36]. IL-10 inhibits the generation of cell-mediated antitumor immunity by inhibiting a broad array of immune parameters including antigen presentation, antigen-specific T cell proliferation, and type 1 cytokine production [37]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pathogenic mechanisms underlying the development of lung cancer are very complex and not yet entirely clarified. T lymphocytes and their immune-regulatory cytokines play a pivotal role in controlling tumor growth and metastasis. Following activation by unique cytokines, CD4+ T helper cells differentiate into Th1, Th2, Th17, and regulatory T cells (Tregs). Traditionally, research in lung cancer immunity has focused almost exclusively on Th1/Th2 cell balance. Recently, Th17 cells and Tregs represent an intriguing issue to be addressed in lung cancer pathogenesis. Tregs play an important role in the preservation of self-tolerance and modulation of overall immune responses against tumor cells. Th17 cells directly or via other proinflammatory cytokines modulate antitumor immune responses. Notably, there is a close relation between Tregs and Th17 cells. However, the possible interaction between these subsets in lung cancer remains to be elucidated. In this setting, targeting Treg/Th17 balance for therapeutic purposes may represent a useful tool for lung cancer treatment in the future. The purpose of this review is to discuss recent findings of the role of these novel populations in lung cancer immunity and to highlight the pleiotropic effects of these subsets on the development and regulation of lung cancer.
    Research Journal of Immunology 04/2014; 2014:730380. DOI:10.1155/2014/730380
    • "Whether IFN-activates MAPK and PI3K pathways via MyD88 leading to IL-27 induction in human monocytic cells remains to be established. IFN-has also been shown to signal via other STAT molecules such as STAT3 or STAT5 (Gough et al. 2008; Meinke et al. 1996; Qing and Stark 2004; Sun and Ding 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: IL-27, a member of the IL-12 cytokine family, is a key immunoregulatory cytokine produced predominantly by monocytic cells and mediates innate and adaptive immune responses. IL-27 has been shown to be produced by human monocytic cells primed with IFN-γ and in response to a second stimulus such as LPS. In this study, we show for the first time that IFN-γ alone without any second stimulus can induce IL-27p28 gene expression and IL-27 protein production by human monocytic cells. The signaling pathways that govern IL-27 production in general, and particularly following stimulation of monocytic cells with IFN-γ are not known. We investigated the signaling pathways governing the regulation of IL-27 protein and its subunit IL-27p28 following stimulation with IFN-γ in primary human monocytic cells. Our results suggest that IFN-γ-mediated IL-27 protein but not IL-27p28 gene expression is positively regulated by the C-Jun N-terminal kinases (JNK), mitogen-activated protein kinases (MAPKs) and the phosphoinositide 3-kinase (PI3K), independent of the Janus kinase (Jak)/signal transducers and activators of transcription (STAT) signaling in primary human monocytes.
    Immunobiology 06/2013; 219(1). DOI:10.1016/j.imbio.2013.06.001 · 3.04 Impact Factor
Show more